Fundraising FoxFibralign Corporation
1 known investors
Find your way into Fibralign Corporation
Sign up to see every warm intro you have to Fibralign Corporation
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fibralign Corporation team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fibralign is a commercial-stage Stanford spinout that develops therapeutic biomedical devices using its Nanoweave scaffolding platform, which prints 3D collagen scaffolds mimicking human tissue structure. Its first product, the BioBridge Collagen Matrix, is used by surgeons to repair damaged lymphatic tissue and treat secondary lymphedema, and is available in the US, Europe, South Korea, and the Middle East.
Investors · 1
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase II | 2019 | $996.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $3M |
| Department of DefenseDefense Health Program | Phase II | 2016 | $988K |
| Department of DefenseDefense Health Program | Phase I | 2015 | $150K |
| U.S. ArmyArmy | Phase II | 2013 | $999.9K |
| National Science Foundation | Phase I | 2013 | $150K |
| U.S. ArmyArmy | Phase I | 2012 | $149.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Fibralign Corporation do?
- Fibralign is a commercial-stage Stanford spinout that develops therapeutic biomedical devices using its Nanoweave scaffolding platform, which prints 3D collagen scaffolds mimicking human tissue structure. Its first product, the BioBridge Collagen Matrix, is used by surgeons to repair damaged lymphatic tissue and treat secondary lymphedema, and is available in the US, Europe, South Korea, and the Middle East.
- Who are Fibralign Corporation's investors?
- Fibralign Corporation's investors include StartX.